Galmarini CM - Search Results

1

Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

Galmarini CM, Clarke ML, Santos CL, Jordheim L, Perigaud C, Gosselin G, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Int J Cancer. 2003 Oct 20;107(1):149-54. doi: 10.1002/ijc.11339. Int J Cancer. 2003. PMID: 12925971

2

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J, Perigaud C, Dumontet C. Jordheim LP, et al. Among authors: galmarini cm. Clin Cancer Res. 2004 Aug 15;10(16):5614-21. doi: 10.1158/1078-0432.CCR-04-0506. Clin Cancer Res. 2004. PMID: 15328204

3

Problems related to resistance to cytarabine in acute myeloid leukemia.

Cros E, Jordheim L, Dumontet C, Galmarini CM. Cros E, et al. Among authors: galmarini cm. Leuk Lymphoma. 2004 Jun;45(6):1123-32. doi: 10.1080/1042819032000159861. Leuk Lymphoma. 2004. PMID: 15359991 Review.

4

[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: galmarini cm. Bull Cancer. 2005 Mar;92(3):239-48. Bull Cancer. 2005. PMID: 15820918 Free article. Review. French.

5

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

Jordheim LP, Guittet O, Lepoivre M, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: galmarini cm. Mol Cancer Ther. 2005 Aug;4(8):1268-76. doi: 10.1158/1535-7163.MCT-05-0121. Mol Cancer Ther. 2005. PMID: 16093443

6

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

Jordheim LP, Galmarini CM, Dumontet C. Jordheim LP, et al. Among authors: galmarini cm. Cancer Chemother Pharmacol. 2006 Oct;58(4):547-54. doi: 10.1007/s00280-006-0195-8. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463058

7

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

8

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

Galmarini CM, Clarke ML, Jordheim L, Santos CL, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. BMC Pharmacol. 2004 May 24;4:8. doi: 10.1186/1471-2210-4-8. BMC Pharmacol. 2004. PMID: 15157282 Free PMC article.

9

Potential mechanisms of resistance to cytarabine in AML patients.

Galmarini CM, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Dumontet C. Galmarini CM, et al. Leuk Res. 2002 Jul;26(7):621-9. doi: 10.1016/s0145-2126(01)00184-9. Leuk Res. 2002. PMID: 12008078

10

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, Cros E, Dumontet C. Galmarini CM, et al. Br J Haematol. 2002 Jun;117(4):860-8. doi: 10.1046/j.1365-2141.2002.03538.x. Br J Haematol. 2002. PMID: 12060121 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters